Drug Safety

The Unknown Impacts of Combinations of Large Numbers of Drugs
pp. 183-185(3)
Authors: Kostoff, Ronald N.; Delafuente, Jeffrey C.

Bill Inman: Drug Safety Physician and Pharmacoepidemiologist
pp. 187-188(2)
Author: Shakir, Saad A.W.

A Preliminary Benefit-Risk Assessment of Verteporfin in Age-Related Macular Degeneration
pp. 189-199(11)
Authors: Wickens, Jason; Blinder, Kevin J.

Safety and Tolerability of the Antibacterial Rifaximin in the Treatment of Travellers' Diarrhoea
pp. 201-207(7)
Author: Ericsson, Charles D.

Camptothecin and Podophyllotoxin Derivatives: Inhibitors of Topoisomerase I and II – Mechanisms of Action, Pharmacokinetics and Toxicity Profile
pp. 209-230(22)
Authors: Hartmann, Jörg T.; Lipp, Hans-Peter

Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
pp. 231-236(6)
Authors: Uzan, Laurent; Guignat, Laurence; Meune, Christophe; Mouly, Stéphane; Weber, Simon; Bertagna, Xavier; Bertherat, Jérôme; Thomopoulos, Pierre; Duboc, Denis

Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans
pp. 237-254(18)
Authors: Aubert, Marion; Osterwalder, Rolf; Wagner, Björn; Parrilla, Isabelle; Cavero, Icilio; Doessegger, Lucette; Ertel, Eric A.

Early First-Trimester Sibutramine Exposure: Pregnancy Outcome and Neonatal Follow-Up
pp. 255-259(5)
Authors: Marco De Santis,; Straface, Gianluca; Cavaliere, Anna F.; Carducci, Brigida; Caruso, Alessandro

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan: An Observational Study
pp. 261-272(12)
Authors: Huang, Weng-Foung; Hsiao, Fei-Yuan; Tsai, Yi-Wen; Wen, Yu-Wen; Shih, Yaw-Tang

Extension of Points on Clarifying Terminology in Drug Safety
pp. 273-275(3)
Authors: Hauben, Manfred; Reich, Lester; Gabbay, Flic